Immunoradiometric Measurement of pS2 in Breast Cancer: Correlation with Steroid Receptors and Plasminogen Activators

Authors

  • Yunus Luqmani From the Kuwait Cancer Control Center, and the Faculties of Allied Health Sciences, Kuwait University, Kuwait
  • Labiba Temmim From the Kuwait Cancer Control Center, and the Faculties of Allied Health Sciences, Kuwait University, Kuwait
  • Anjum Memon Medicine, Kuwait University, Kuwait
  • Abdulhamid Parkar From the Kuwait Cancer Control Center, and the Faculties of Allied Health Sciences, Kuwait University, Kuwait
  • Majda Ali From the Kuwait Cancer Control Center, and the Faculties of Allied Health Sciences, Kuwait University, Kuwait
  • Mohammed Motawy From the Kuwait Cancer Control Center, and the Faculties of Allied Health Sciences, Kuwait University, Kuwait
  • Hisham Baker From the Kuwait Cancer Control Center, and the Faculties of Allied Health Sciences, Kuwait University, Kuwait

DOI:

https://doi.org/10.1080/028418699432978

Abstract

pS2 was measured by radioimmunometric assay in tumour extracts from 197 breast cancer patients. Values ranged from 0 to 50 ng/mg protein (mean 9.6 and median 3 ng/mg). We found no correlation with age, menopausal status, nodal metastases, disease stage or tumour histology. There was, however, a linear relationship with both ER (p<0.0001) (particularly nuclear ER) and PR (p

Downloads

Download data is not yet available.

Downloads

Published

1999-01-01

How to Cite

Luqmani, Y., Temmim, L., Memon, A., Parkar, A., Ali, M., Motawy, M., & Baker, H. (1999). Immunoradiometric Measurement of pS2 in Breast Cancer: Correlation with Steroid Receptors and Plasminogen Activators. Acta Oncologica, 38(6), 805–814. https://doi.org/10.1080/028418699432978

Issue

Vol. 38 No. 6 (1999): Acta Oncologica

Section

Articles